Literature DB >> 12393721

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis.

Frederique Ponchel1, Ann W Morgan, Sarah J Bingham, Mark Quinn, Maya Buch, Robert J Verburg, Judy Henwood, Susan H Douglas, Aurelie Masurel, Philip Conaghan, Moji Gesinde, Julia Taylor, Alexander F Markham, Paul Emery, Jacob M van Laar, John D Isaacs.   

Abstract

Rheumatoid arthritis (RA) is a chronic, inflammatory disease of the synovium of uncertain pathogenesis. A number of phenotypic and functional T-cell defects have been described in RA, including abnormal clonal expansions and suppressed proliferative responses, which suggest a defect in T-cell differentiation. Here, we show that RA patients possess fewer naive CD4(+) T cells than healthy controls. Furthermore, a smaller proportion of these cells contains a T-cell receptor excision circle (TREC). Patients with RA also have unusual populations of T cells. These include immature cells characterized as CD45RB(bright)CD45RA(+)CD62L(-) by flow cytometry and a large population that coexpresses CD45RA and CD45RO. These cells are hyperresponsive to mitogen and TCR stimulation when compared to naive cells. Additionally, an unusual putative central memory subset expressing CD62L, but not CD45RA, appears in RA patients at the expense of more typical cells. Levels of C-reactive protein correlate inversely with the TREC content of naive T cells and positively with the sizes of naive and immature atypical T-cell subsets. These data suggest that inflammation drives proliferation of naive T cells in RA and encourages their differentiation into atypical, hyperresponsive progeny. TREC content of individual naive and atypical T-cell subsets suggests an ontogeny consistent with this hypothesis. These studies provide further evidence of a T-cell differentiation defect in RA, which could explain some of the well-characterized immunologic features of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393721     DOI: 10.1182/blood-2002-03-0671

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Keeping hopes high.

Authors:  Jocelyne Demengeot; Shohei Hori
Journal:  EMBO Rep       Date:  2003-10-24       Impact factor: 8.807

Review 2.  T cell apoptosis and inflammatory bowel disease.

Authors:  M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

3.  Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat.

Authors:  Max Brenner; Teresina Laragione; Nuriza C Yarlett; Pércio S Gulko
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 4.  Co-stimulatory blockade as therapy for rheumatoid arthritis.

Authors:  Sarah L Mackie; Edward M Vital; Frederique Ponchel; Paul Emery
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

Review 5.  Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis.

Authors:  Roxana Coras; Rekha Narasimhan; Monica Guma
Journal:  Transl Res       Date:  2018-07-19       Impact factor: 7.012

6.  K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis.

Authors:  Karnail Singh; Pratima Deshpande; Guangjin Li; Mingcan Yu; Sergey Pryshchep; Mary Cavanagh; Cornelia M Weyand; Jörg J Goronzy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

7.  Therapeutic effects of lactosyl derivative Gu-4 in a collagen-induced arthritis rat model.

Authors:  Jie Fan; Huiting Zhou; Shihui Wang; Hailian Wang; Yushun Zhang; Yingtao Guo; Qing Li; Zhongjun Li; Zhihui Zhao
Journal:  Glycoconj J       Date:  2012-06-12       Impact factor: 2.916

Review 8.  Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?

Authors:  Kristina Schreiber; Gaetane Nocturne; Divi Cornec; Claire I Daïen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

9.  ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis.

Authors:  Karnail Singh; Pratima Deshpande; Sergey Pryshchep; Inés Colmegna; Vladimir Liarski; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Authors:  P Stolt; H Källberg; I Lundberg; B Sjögren; L Klareskog; L Alfredsson
Journal:  Ann Rheum Dis       Date:  2004-08-19       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.